Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis
暂无分享,去创建一个
Gang Wang | Ziming Li | Lei Zhu | Guangyu Tao | Qunhui Chen | Lingming Yu | Jianding Ye | G. Wang | Lei Zhu | Lingming Yu | G. Tao | Ziming Li | Jianding Ye | Qun-hui Chen
[1] Andrew H. Beck,et al. Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer , 2017, JAMA.
[2] Kujtim Latifi,et al. Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall‐cell lung cancer patients treated with stereotactic body radiotherapy , 2017, Medical physics.
[3] Fumihiro Tanaka,et al. The prognostic significance of HER2 overexpression in non-small cell lung cancer. , 2011, Anticancer research.
[4] Paulo Mazzoncini de Azevedo Marques,et al. Radiomics-based features for pattern recognition of lung cancer histopathology and metastases , 2018, Comput. Methods Programs Biomed..
[5] Shu-Ju Tu,et al. Localized thin-section CT with radiomics feature extraction and machine learning to classify early-detected pulmonary nodules from lung cancer screening , 2018, Physics in medicine and biology.
[6] Paul J. Perry,et al. A Review for the Clinician , 2002 .
[7] Prateek Prasanna,et al. Radiomics and radiogenomics in lung cancer: A review for the clinician. , 2018, Lung cancer.
[8] Morihito Okada,et al. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. , 2012, The Journal of thoracic and cardiovascular surgery.
[9] P. Lambin,et al. Predicting outcomes in radiation oncology—multifactorial decision support systems , 2013, Nature Reviews Clinical Oncology.
[10] P. Lambin,et al. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] Boris Sepesi,et al. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer. , 2017, International journal of radiation oncology, biology, physics.
[12] Senén Barro,et al. An extensive experimental survey of regression methods , 2019, Neural Networks.
[13] Patrick Granton,et al. Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.
[14] Hidetaka Arimura,et al. Exploration of temporal stability and prognostic power of radiomic features based on electronic portal imaging device images. , 2018, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[15] M. Li,et al. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway. , 2018, European review for medical and pharmacological sciences.
[16] Peter Balter,et al. Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer , 2017, Scientific Reports.
[17] Takashi Nakajima,et al. Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer: A Clinicopathologic Study , 2007, Clinical Cancer Research.
[18] Jin Mo Goo,et al. The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors , 2017, PloS one.
[19] Cheng-Yi Cheng,et al. Predictive Value of 18F-FDG PET and CT Morphologic Features for Recurrence in Pathological Stage IA Non-Small Cell Lung Cancer , 2015, Medicine.
[20] Yoichi Kameda,et al. Sublobar resection for patients with peripheral small adenocarcinomas of the lung: surgical outcome is associated with features on computed tomographic imaging. , 2007, The Annals of thoracic surgery.
[21] Liu Yang,et al. Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma. , 2017, The American journal of pathology.
[22] Bin Zhang,et al. Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma. , 2017, Cancer letters.
[23] D. Libby,et al. Tumor size predicts survival within stage IA non-small cell lung cancer. , 2003, Chest.
[24] João Manuel R. S. Tavares,et al. Automatic 3D pulmonary nodule detection in CT images: A survey , 2016, Comput. Methods Programs Biomed..
[25] Jae Kwon Kim,et al. A Performance Comparison on the Machine Learning Classifiers in Predictive Pathology Staging of Prostate Cancer , 2017, MedInfo.
[26] Kyung Soo Lee,et al. Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma , 2016, Oncotarget.
[27] Federico González-Aragoneses,et al. Multicenter analysis of survival and prognostic factors in pathologic stage I non-small-cell lung cancer according to the new 2009 TNM classification. , 2011, Archivos de bronconeumologia.
[28] Xiao Liang,et al. Novel radiomic signature as a prognostic biomarker for locally advanced rectal cancer , 2018, Journal of magnetic resonance imaging : JMRI.
[29] Roberto Maroldi,et al. Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy , 2013, European Radiology.
[30] Carsten Brink,et al. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] S. Perner,et al. [Translational research and diagnostics in lung cancer]. , 2012, Der Pathologe.
[32] Yi Lu,et al. Application of Machine Learning Approaches for the Design and Study of Anticancer Drugs. , 2019, Current drug targets.
[33] Roy S. Herbst,et al. The biology and management of non-small cell lung cancer , 2018, Nature.
[34] Byung-Tae Kim,et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. , 2005, Radiology.
[35] Pablo León-Atance,et al. Análisis multicéntrico de supervivencia y factores pronósticos en el carcinoma no microcítico de pulmón en estadio I patológico según la nueva clasificación TNM de 2009 , 2011 .
[36] Vicenta S Martínez-Zorzano,et al. Erythrocyte fatty acids as potential biomarkers in the diagnosis of advanced lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer. , 2014, American journal of clinical pathology.